SCHEMBL6705228

SCHEMBL6705228

CCOC(=O)CC1(O)CCC(C)(C)c2ccc(/N=N/c3ccccc3C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
GAA P10253 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
IDE P14735 1/20 0.40
MYC P01106 1/20 0.39
MAPK1 P28482 2/20 0.39
PSMD14 O00487 1/20 0.39
HSP90AA1 P07900 1/20 0.39
MMP2 P08253 1/20 0.39
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RXRA P19793 8/20 0.36
RXRG P48443 6/20 0.36
RXRB P28702 5/20 0.36
ALDH1A1 P00352 2/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6298088 1.00 MAPT (0.43) MAPTMEN1KMT2AGAANPSR1
SCHEMBL7639547 0.87 RXRA (0.39) GAARXRARXRGRXRBHNF4A
SCHEMBL7639556 0.87 RXRA (0.39) GAARXRARXRGRXRBHNF4A
SCHEMBL8644410 0.85 RXRA (0.46) NPSR1RXRARXRGRXRBALDH1A1
SCHEMBL6297429 0.81 MAPT (0.46) MAPTMEN1KMT2ARXRARXRG
SCHEMBL6297432 0.81 MAPT (0.46) MAPTMEN1KMT2ARXRARXRG
SCHEMBL8901599 0.77 GAA (0.47) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL6292622 0.74 RARB (0.40) MAPTMEN1KMT2AGAANPSR1
SCHEMBL9058220 0.73 RARB (0.65) RXRARXRGRXRBRARBRARG
SCHEMBL6293872 0.72 RARB (0.67) NPSR1RXRARXRGRXRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127469-A1 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity JOHNSON ALAN T (US) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127469-A1 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity RARB, RARA, RXRB MAPT 4431/4885MEN1 2555/4885KMT2A 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.